Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human PathogenTrypanosoma cruzi

Approaches for the Development of New Anti-Trypanosoma cruzi Agents

(2009) Diogo Rodrigo Magalhaes Moreira et al.   CURRENT DRUG TARGETS

Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human Infections

(2009) Galina I. Lepesheva et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Indomethacin Amides as a Novel Molecular Scaffold for TargetingTrypanosoma cruziSterol 14α-Demethylase

(2009) Mary E. Konkle et al.   JOURNAL OF MEDICINAL CHEMISTRY

Chagas disease travels to Europe

(2009) Luis Ignacio Gonzalez-Granado et al.   LANCET

Current status and perspectives of cell therapy in Chagas disease

(2009) Milena Botelho Pereira Soares et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Ergosterol biosynthesis and drug development for Chagas disease

(2009) Julio A Urbina   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy

(2009) Álvaro Moncayo et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Trypanosoma cruzitargets for new chemotherapeutic approaches

(2008) Maria Nazaré C Soeiro et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Update on Azole Antifungals

(2008) Dimitrios Zonios et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

(2007) Z. A. Kanafani et al.   CLINICAL INFECTIOUS DISEASES